Reversal Of Type 2 Diabetes
A study found that men with physical activity and women with lower waist circumference can reverse type 2 diabetes. The following factors can cause diabetes in men.
Following factors cause diabetes in women.
Devices From Diasend
Diasend in collaboration with Abbott has introduced Freestyle Libre wireless glucose monitoring system. Patients can import data into the Diasend device with the FreeStyle LibreLink App. The patient can connect to the Android Smartphone with the LibreLink App and a FreeStyle Libre sensor.
Freestyle Libre is a specially designed wireless sensor, of the size of a 20 cent coin, to check the blood glucose levels continuously without taking the blood from the body (a non-invasive procedure). The sensor can measure glucose levels by inserting a tiny pin into the arm. The sensor is a water resistant and with an adhesive backing. A patient can get the blood glucose (sugar) data in less than a second. The patient can view, upload and store data from devices compatible with Diasend devices such as.
Risk With Cardiovascular Disease (CVD) History
A study shows higher-than-normal cholesterol levels in children with a history of cardiovascular disease (CVD) and/or with type 2 diabetes (T2D). Type 2 diabetes and cardiovascular diseases are associated with unfavorable levels of cardiometabolic markers.
The study was published in the Diabetologia.
Memorandum Of Understanding (MOU) Between Singhealth And Medtronic
Singhealth (Singapore), a public healthcare group, signed MOU with Medtronic International Limited (Ireland) on 31st May 2016. They are collaborating in areas of.
The global medical technology company, Medtronic announced that they are opening Asia Pacific regional office in Mapletree Business City in Pasir Panjang. Medtronic announced that they are going to make a next-generation MRI-safe pacemaker, cardiac monitoring devices and other products from Singapore.
Eating unhealthy foods with high fat, salt and sugar without physical activity can increase the risk of type 2 diabetes.
Treatment With Jentadueto XR
FDA has approved Jentadueto XR tablets for the treatment of type 2 diabetes (T2D) in adult patients. JENTADUETO XR is an extended-release therapy. The drug can provide the convenience of a combination of linagliptin and metformin (2.5/5 mg of linagliptin + 1000 mg of metformin).
Once a day pill will improve glycemic control and blood sugar levels. Linagliptin works by increasing the hormones. The increased hormones stimulate the pancreas. After stimulation, the pancreas can make more insulin. Linagliptin act on the liver to produce less glucose. The company says JENTADUETO XR should not be used for.
Jentadueto XR tablets may cause a risk of lactic acidosis. The patient should seek medical help in the following situations.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.